Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 31
Back to Home
Thymosin Alpha-1
EfficacyHigh
Studies8
Participants1,847
StatusAvailable

Thymosin Alpha-1

Tα1, N-Acetyl-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn

Thymosin Alpha-1 is a potent immunomodulatory peptide that enhances T-lymphocyte function, activates natural killer cells, and strengthens both innate and adaptive immune responses. Originally derived from the thymus gland, it plays a crucial role in immune system maturation and has been extensively studied for treating viral infections, cancer, and immunodeficiency disorders.

Clinical Safety Profile

Reported Side Effects

Mild injection site reactions (redness, swelling)
Temporary fatigue during initial immune activation
Occasional mild flu-like symptoms
Rare autoimmune activation in predisposed individuals
Mild lymphadenopathy (swollen lymph nodes)
Transient changes in white blood cell counts

Side Effect Management (Clinical Trial Data)

Injection Site Reactions
Common
15.2%
Mild Fatigue
Infrequent
8.7%
Transient Flu Like Symptoms
Infrequent
6.3%
Lymphadenopathy
Infrequent
4.1%
Mood Changes
Infrequent
2.8%

Side Effect Management Strategies

Nausea: Take with food, smaller meals, ginger supplements
Vomiting: Slower dose escalation, anti-emetics if severe
Diarrhea: Adequate hydration, probiotics, bland diet
Constipation: Increase fiber intake, adequate fluids, light exercise

Clinical Safety Metrics

Variable
Overall Safety Rating
Variable
Discontinuation Rate
Research
Approved Status

CONTRAINDICATIONS

• Active autoimmune diseases without medical supervision
• Severe immunosuppressive therapy
• Hypersensitivity to thymosin compounds
• Pregnancy and breastfeeding (insufficient data)

Medical Disclaimer

Thymosin Alpha-1 is an investigational peptide not approved by the FDA for medical treatment in the United States. This information is for educational purposes only and should not replace professional medical advice. Consult healthcare providers before use, especially for immune-related conditions or during medical treatments.